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GENERAL INTRODUCTION 
Phosphorylase h kinase (ATP: phosphorylase h 
phosphotransferase, EC 2.7.1.38) plays a crucial role in the 
regulation of glycogenolysis. It catalyzes the conversion 
of phosphorylase b to an active a form by transferring the y 
phosphate of ATP to the alcoholic group of Ser-14 in 
phosphorylase. The phosphorylase a then facilitates the 
breakdown of glycogen to glucose-l-phosphate. 
Phosphorylase kinase is mainly found in skeletal muscle 
(1), constituting about 0.5% of the soluble proteins, but is 
also found in many other tissues including smooth muscle 
(2), heart (3,4), liver (5-7), adipose tissue (8), platelets 
(9) and brain (10). The enzyme was first isolated by Krebs 
et al. (1) from rabbit skeletal muscle and later purified to 
a homogeneous form by Cohen (11) and Hayakawa et al. (12) . 
Enzymes purified from all sources show similar 
characteristics, e.g., physical properties, enzymatic 
activities, and mode of regulation. By far the most results 
are from the studies of the skeletal muscle enzyme and these 
results constitute the main body of this Introduction. 
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General Properties of Phosphorylase kinase 
The homogeneous rabbit skeletal muscle phosphorylase 
kinase is a huge and complex protein with a molecular mass 
of approximately 1300 kDa (11,12), The holoenzyme is a 
hexadecamer and composed of four different subunits, a, p,y, 
and 6, with a stoichiometry of (a^yS) 4 (11). Molecular 
weights of subunits, based on their sequences, are a= 
138,422 (1237 amino acid residues)(13); p= 125,205 (1092 
amino acid residues) (14) ; 7= 44,673 (386 amino acid 
residues) (15); and 6 = 16,680 (148 amino acid residues) 
(16). Two isozymic forms of phosphorylase kinase have been 
identified and isolated from white (fast-twitch) and red 
(slow-twitch) muscles (17,18) They differ in the size of 
their largest subunits, which are designated a and a' . The 
difference in physiological functions between the two 
isozymes is not clear. The sedimentation coefficient of 
phosphorylase kinase is 23S, as determined by Cohen (11) or 
26.IS by Hayakawa et al. (12). The frictional coefficient 
(f/fO) of the holoenzyme is 1.17 and the isoelectric point 
is 5,77 as determined by sucrose density gradient 
isoelectric focusing (12). 
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Roles of Subunits 
The catalytic subunib 
The role of the y subunit in the phosphotransferase 
activity of phosphorylase kinase was first proposed by 
Hayakawa et al. (12) in 1973. This proposal was based on 
the observation that partial proteolysis by trypsin 
activates the kinase activity of holoenzyme. The trypsin 
digestion dissected a and P but not the y subunit and 
generated some active complexes containing mainly the y 
subunit (19) . The y subunit contains the catalytic activity 
of phosphorylase kinase and was proved by the observations 
of Skuster et al. (20), Chan and Graves (21-23), Kee and 
Graves (24,25) in the early and mid 80's. Two active 
complexes, ayS and yS, were isolated and purified by treating 
the holoenzyme of phosphorylase kinase with a strong 
chaotropic salt, LiBr, at low temperature (21). A further 
characterization suggested that both complexes exhibit 
almost the full kinase activity of holoenzyme (22). 
Additionally, autophosphorylation could occur in ayô. 
Although yS could not phosphorylate itself it did 
phosphorylate and activate phosphorylase kinase. More 
direct evidence about the role of y came from the studies of 
Kee and Graves (24,25). Their studies showed that the 
renatured HPLC-purified y subunit also contained 
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phosphorylase kinase activity and phosphorylated 
phosphorylase. Kinetic studies suggests that the 
reactivated y subunit has similar Km values as those of 
holoenzyme against both substrates (98 |JM for MgATP and 80 
liM for phosphorylase b (25) ) . The Vm, however, is about 10-
fold lower. 
Primary sequence alignment in the catalytic domain of 
various kinases (26) provides additional evidence for the 
role of Y in phosphotransferase activity of phosphorylase 
kinase. According to the sequence alignment, the N-terminal 
276 amino acid residues of y contains a catalytic domain 
with a homology of around 40% with that of cAMP-dependent 
protein kinase and other kinases. The homology of conserved 
residues in y which are important for kinase activity is 
even higher. The C-terminus (301-386) of y is believed to 
be the calmodulin binding domain according to the studies of 
Dasgupta et al. (27) and James et al. (28). 
The expression of the full length y subunit (1-386) in 
E. coli. (29) and other systems (30,31) has been performed 
by our and other laboratories. However, purification of the 
recombinant y subunit to homogeneity is difficult. Recently 
our lab (32) and another laboratory (33) showed that the 
expression of the N-terminal catalytic domain of y(1-300), 
denoted as a truncated form of y or TR-y, was feasible and 
the enzyme could be purified to homogeneity. There are 
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several advantages of using TR-y over full length y; (i) TR-y 
has higher catalytic activity than y, (ii) TR-y can be 
purified to homogeneity, and (iii) TR-y, missing the 
inhibitory C-terminal calmodulin binding domain (34), can be 
used to probe more directly the catalytic function of 
phosphorylase kinase. TR-y subunit is used in this thesis 
for the studies of tyrosine kinase activity of phosphorylase 
kinase and the role of free sulfhydryl groups in the 
catalytic domain of y. 
The S subunit and its function 
The 6 subunit was not found until 1978 (35), largely 
because of its small size and poor staining after gel 
electrophoresis with typical protein stains. It was found 
essentially identical to bovine brain calmodulin in its 
primary sequence and in its ability to activate calmodulin-
dependent enzymes (35). The amino acid sequence of the ô 
subunit differs only at two residues from that of bovine 
brain calmodulin (36) . Calmodulin is a member of a group of 
Ca2+ binding proteins mediating the control of a variety of 
enzymes in response to physiological fluxes of Ca2+. Thus, 
the 6 subunit acts as a built-in sensor for Ca2+ and confers 
Ca2+-sensitivity to phosphorylase kinase. Muscle 
phosphorylase kinase is a Ca^+-dependent enzyme and requires 
Ca2+ for its activity. The comparison of the Ca2+ binding 
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properties of holoenzyme and the isolated 6 subunit by 
Heilmeyer et al. (37) and Kohse and Heilmeyer (38) indicates 
that the holoenzyme binds Ca2+ exclusively through the 5 
subunit. Different from other calmodulin-dependent enzyme 
systems, the 5 subunit is an integral part of phosphorylase 
kinase and associates with the holoenzyme tightly even in 
the presence of EGTA (15,35,39). 
The regulatory subunits: a and (3 
The a and P subunits are partly homologous in primary 
sequence except for an N-terminal sequence that is unique to 
P and two sequences in the middle of a not seen in P (14). 
They serve as the regulatory subunits in phosphorylase 
kinase. The activation of the holoenzyme is due to the 
phosphorylation of the a and P subunits by either cAMP-
dependent protein kinase (11,40) or by Ca2+-dependent 
autophosphorylation (1,41). A total of 10 phosphorylation 
sites on a and P are known, i.e., 7 on a and 3 on p. Nine 
of ten known phosphorylation sites are located (13,14). The 
activation of phosphorylase kinase catalyzed by cAMP-
dependent protein kinase is initiated by the phosphorylation 
of the P subunit. The phosphorylation of a does not occur 
until at least 1 mole phosphate/(apyS) 4 has been 
incorporated into the p subunit (11). The phosphorylation 
in p is essential for activation and independent of the 
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level of phosphorylation in a (42) . Modification of a may 
be important in sustaining an activation level of the 
holoenzyme (12,42-44). The phosphorylation of the a subunit 
alone does not affect kinase activity (11,42,45,46). In the 
presence of Ca2+, Mg2+, and ATP, phosphorylase kinase 
undergoes autophosphorylation and autoactivation by the 
incorporation of phosphates into multiple sites in the a and 
P subunits (41,47,48). The autophosphorylation is an 
intrinsic activity and intramolecular process of 
phosphorylase kinase (49,50). The observation that the same 
site in the P subunit can be phosphorylated by either cAMP-
dependent protein kinase or by autophosphorylation (51) 
indicates the similarity in the mechanism of the activation 
of holoenzyme by two different processes. 
Beside the phosphorylation sites, the a and P subunits 
also contain calmodulin binding sites. The binding of 
calmodulin • Ca2+ complex to the a and P subunits (52) 
activates phosphorylase kinase (53-55). The interaction 
between exogenous calmodulin and a and P is Ca2+-dependent 
and can be inhibited by trifluoperazine, phosphodiesterase, 
calcineurin, and calmodulin-binding peptides, e.g., melittin 
and mastoparan. It has been demonstrated that calmodulin 
and cAMP-dependent protein kinase regulate the activity of 
phosphorylase kinase in a complementary manner (56) . The 
binding of calmodulin can prevent P from phosphorylation by 
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cAMP-dependent protein kinase and vice versa. Several 
possible calmodulin binding sequences in a and (3 have been 
proposed (13,14) based on their primary sequences with those 
of other calmodulin-binding peptides. A possible calmodulin 
binding site near the N-terminus of the (3 subunit rich in 
basic, hydrophobic and aromatic residues is postulated to 
play an important role in a complementary regulation of 
holoenzyme, because it serves also as the substrate for 
phosphorylation (14). 
The a and P subunits in holoenzyme may act as the 
negative regulators to exert an inhibitory effect to the 
catalytic y subunit of phosphorylase kinase (15,57-59). The 
phosphorylase kinase can be activated by treating with 1.8 M 
LiBr which dissociates holoenzyme into small active 
complexes (15) . Paudel and Carlson (57) found that isolated 
renatured a/P mixture inhibits the activity of reactivated 
y. Peptides isolated from proteolyzed P subunit (58) or 
synthesized upon the sequence of postulated calmodulin 
binding sites in P (59) are found to inhibit the activity of 
phosphorylase kinase. The inhibitory effect of a/P and 
inhibitory peptides can be relieved by phosphorylation and 
calmodulin binding. These results suggests that the a 
and/or P subunits may be intimately involved in the 
regulation of phosphotransferase activity of phosphorylase 
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kinase by directing an inhibitory domain to the active site 
region in y. 
Catalytic Properties 
Nature of phosphotransferase activity of phosphorvlase 
kinase 
Phosphorylase kinase requires Mg2+ to form an active 
substrate with ATP, MgATp2~, for its phosphotransferase 
activity. However, Mg2+ added in excess of that required to 
form the substrate can further stimulate the activity of 
phosphorylase kinase (60,61). The stimulatory effect of 
free Mg2+ was seen as an increase in Vm and a decrease in Km 
for both substrates, MgATP and phosphorylase b (62). The 
reactivated HPLC-y subunit can also be stimulated by free 
Mg2+(25) . The level of stimulation by Mg2+ in y is the same 
as that of stimulation in holoenzyme. Accordingly, an 
additional metal ion binding site in y was proposed (25). 
In contrast, Mn2+ was found to activate at lower and inhibit 
at higher concentrations the activity of both the 
reactivated y subunit (25) and holoenzyme (61) . 
Nonactivated phosphorylase kinase has little activity at 
physiological pH (around 7.0), but exhibits a considerable 
activity at higher pH (1). The pH dependency of 
phosphorylase kinase is changed by the activation via 
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phosphorylation, calmodulin binding, and proteolysis. The 
ratio of activity at pH 6.8 to at 8.2 is 0.04-0.08 for 
nonactivated enzyme and 0.3-1.0 for activated forms, 
respectively (63). The difference in pH-dependency among 
different enzyme forms suggests that a functional group in 
the active site region important for catalysis may be 
affected by the state of activation. The idea of a 
catalytic base helping to pull a proton from a reactive 
seryl residue in substrates during catalysis was proposed by 
Yoon and Cook (64), and Taylor et al. (65) to explain the 
high turnover rate of serine kinases. The "proton pulling" 
ability of this catalytic base could be affected by its pKa 
and the pH value of the surrounding environment. In 
phosphorylase kinase, the pH-dependency change that occurs 
upon activation may reflect a change in the microenvironment 
of the catalytic base in the active site region and, hence, 
its pKa value. If the active site region becomes more 
hydrophilic during activation, the putative catalytic base, 
a carboxyl group of an aspartate residue, could become more 
ionized at physiological pH. In this ionized form the 
carboxylate could serve to H-bond or pull a proton away from 
the phosphorylatable serine. 
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Substrate specificity 
Phosphorylase h is known to be an in vivo substrate of 
phosphorylase kinase. In the cell it associates with a 
glycogen particle along with phosphorylase kinase (66). 
Phosphorylase kinase catalyzes the formation of 
phosphorylase a by phosphorylation of a serine residue at 
position 14 in glycogen phosphorylase (67) . A series of 
studies were done using synthetic peptide derivatives 
according to the phosphorylation site sequence (^Ser-Arg-
Pro-Leu-Ser-Asp-Gln-Glu-Lys-Arg-Lys-Gln-Ile-Ser-Val-Arg-Gly-
LeulS) (68-70) . The results suggest that (i) basic amino 
acid residue is required on both N- (P-3) and C-terminal 
(P+2) sides of the phosphorylatable serine, (ii) threonine 
cannot replace serine as a phosphate group acceptor, (iii) 
the first eight amino acid residues may not be important. 
Besides phosphorylase b/ glycogen synthase (53,71,72), 
troponin I (73), troponin T (74,75), casein (76), myosin 
light chain (77),and several other proteins can be 
phosphorylated in vitro by phosphorylase kinase. These 
proteins are not phosphorylated, however, as effectively as 
phosphorylase The proteins are also phosphorylated on 
serine except for troponin I which is phosphorylated on 
threonine (73). 
Phosphorylase kinase may play a different role in 
addition to the regulation of phosphorylase. First, it has 
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been found that the glycogen particle is not the only place 
that phosphorylase kinase is located. About 20-30% of the 
kinase is glycogen bound (67), whereas, phosphorylase b, 
when isolated, is totally associated with the glycogen 
particle. Second, a membrane-bound form of phosphorylase 
kinase is reported (78) and may be anchored through the C-
terminus of the a and p subunits of phosphorylase kinase 
which contain an isoprenoid group. The isoprenylation is 
largely seen in G-proteins and oncoproteins (79) as a 
membrane anchor (80) . Third, it was found that 
phosphorylase kinase exhibited phosphatidyl-inositol kinase 
activity and catalyzed the formation of 
phosphatidylinositol-4-phosphate (81). Fourth, it may exist 
with different active site conformations from that for 
phosphorylase b and accommodate a different substrate. This 
speculation is supported by the finding that both 
phosphorylase kinase and HPLC-isolated y-calmodulin complex 
exhibit different substrate specificity and, hence, pH-
dependency to syntide-2 and syntide-3 in the presence of 
different ligands, Ca2+ and heparin (82). All of these data 
suggest that phosphorylase kinase may contribute to 
different signal transduction pathways other than just being 
involved in the regulation of glycogen metabolism. Many 
studies remain to be done before a full understanding of the 
role of phosphorylase kinase in the cell can be appreciated. 
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Explanation of Dissertation Format 
This dissertation consists of three papers after the 
general introduction. The first paper describes the 
tyrosine kinase activity of phosphorylase kinase. It was 
published in J. Biol. Chem. 268. 17683-17686 (1993). The 
second and third papers deal with the characterizations of 
the free sulfhydryl groups in the catalytic subunit of 
phosphorylase kinase by using biochemical and molecular 
biological methods. These two papers will be submitted to 
the J. Biol. Chem. for publication. Following the third 
paper is the general summary and discussion. The references 
cited in the general introduction are listed following the 
general summary and discussion. 
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PAPER 1. PHOSPHORYLASE KINASE: A METAL lON-DEPENDENT 
DUAL SPECIFICITY KINASE 
15 
Chiun-Jye Yuan, Chi-Ying F. Huang, and Donald J. Graves 
Department of Biochemistry and Biophysics, 
Iowa State University, 
Ames, Iowa 50011 
This research was supported by Grant GM-09587 from the 
National Institutes of Health. This is Journal paper J-
15379 of the Iowa Agriculture and Home Economics Experiment 
Station, Ames, lA, Project No. 2120. 
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SUMMARY 
Phosphorylase kinase is shown to be a dual specificity 
kinase. The specificity of phosphorylation is determined by 
divalent cation. Mg2+ causes seryl phosphorylation of 
phosphorylase b, but Mn2+ activates tyrosine phosphorylation 
of angiotensin II. In contrast to seryl phosphorylation, the 
tyrosine kinase activity of holoenzyme is not regulated by 
Ca2+, Preincubation of the holoenzyme with Ca2+, Mg2+ and 
ATP which causes autophosphorylation activates tyrosine 
kinase activity. The tyrosyl kinase activity is a property 
of the g subunit. Addition of varying amounts of Mn2+ to a 
truncated form of the g subunit of phosphorylase kinase 
containing MgATP inhibits serine kinase, but activates 
tyrosine kinase activity. This result along with an 
oxidative reaction caused by Cu2+ and site-directed 
mutagenesis of the putative catalytic base inhibiting both 
serine and tyrosine kinase activity suggest that one active 
site is involved in both activities. Kinetic studies with 
Mn2+ and ATP show that Km for nucleotide is not changed with 
a seryl or tyrosyl substrate. The Vm values are different 
and the value for tyrosyl phosphorylation is similar to other 
tyrosyl kinases. We propose two conformations for the active 
site, one favors seryl phosphorylation and the second tyrosyl 
phosphorylation caused by the binding of divalent cation at a 
second metal ion binding site. 
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INTRODUCTION 
Protein kinases modulate diverse physiologic processes by 
catalyzing the incorporation of a phosphate group into the 
side chain of various amino acid residues of proteins. 
Several amino acids can serve as acceptors of phosphate, but 
the alcoholic group of serine and threonine, and the phenolic 
group of tyrosine are the major targets for protein kinases 
(1,2). Recently, it has been shown that the imidazole group 
of histidine can be phosphorylated by histidine protein 
kinase (3) . Most protein kinases show selectivity and 
phosphorylate the side chain of only one of the functional 
groups, but some protein kinases have been found to 
phosphorylate more than one type of amino acid residues, and 
are termed dual-specificity kinases (4). MAP kinase kinase, 
a member of this family, can autophosphorylate and 
phosphorylate MAP kinase on alcoholic and phenolic groups (5-
7). These dual specificity kinases are not very different in 
primary structure of their catalytic cores from that of the 
tyrosine kinases and the serine/threonine kinases (4) . 
Little is known about what structural features and factors 
are important for dual specificity. 
Protein kinases require a divalent cation along with a 
nucleoside triphosphate for effective phosphorylation. 
Serine/threonine kinases use Mg2+ more effectively than Mn2+ 
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but tyrosyl kinases differ because Mn2+ stimulates 
phosphorylation equal to or better than that caused by Mg2+ 
(8). Several serine/threonine protein kinases, including 
cAMP-dependent protein kinase (9) and phosphorylase kinase 
(10,11), have been shown to bind more than one metal ion. 
The binding of the additional metal ion may either activate 
or inhibit kinase activity. Results obtained from x-ray 
crystallography of the catalytic subunit of cAMP-dependent 
protein kinase (12,13), a serine kinase, show that two metal 
ion binding sites exist and these sites are in close 
proximity. Occupancy of the first site activates 
phosphotransfer activity but binding at the second site 
inhibits the reaction. Phosphorylase kinase, a calcium 
dependent protein kinase which regulates glycogen metabolism 
(14,15) by phosphorylating a single seryl residue per 
monomeric unit of phosphorylase (841 amino acid residues), 
also contains two metal ion binding sites associated with its 
catalytic subunit. In this instance, binding of divalent 
cation, i.e., Mg2+, at the second site can activate the 
reaction with phosphorylase b but the activity is inhibited 
by the binding of Mn+^ (10) . Phosphorylase kinase acts on few 
other substrates, but it can phosphorylate a threonine 
residue in troponin I (16) and even inositol in 
phosphatidylinositol (17). 
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We report in this communication that the binding of 
second divalent cation in the recombinant catalytic subunit 
of phosphorylase kinase determines enzyme specificity. With 
Mg2+, seryl phosphorylation occurs, but with Mn2+ tyrosine 
phosphorylation is favored. Similar results are seen with 
the holoenzyme, i.e., phosphorylase kinase has tyrosine 
kinase activity in the presence of Mn2+. 
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EXPERIMENTAL PROCEDURES 
Materials 
Highly purified rabbit skeletal muscle phosphorylase 
kinase was a kind gift from Dr. G. M. Carlson of the 
University of Tennesee. Recombinant truncated 7 subunit (1-
300) of phosphorylase kinase is expressed, purified and 
renatured as described by Huang et al. (18). Phosphorylase b 
is prepared as described (19). Angiotensin II 
(AspArgValTyrlleHisProPhe) is from Sigma. Phosphocellulose 
paper and ET-31 filter paper are from Whatman. [y-^^PJ-ATP is 
the product of ICN. Other reagents used in experiments are 
reagent grade. 
Protein concentration determination 
The concentration of phosphorylase kinase and 
phosphorylase b is determined spectrophotometrically (20,21) 
Angiotensin II solution is prepared based on its dry weight. 
The concentration of truncated y subunit is determined by 
reaction with Bradford reagent (Bio-Rad). 
Activity assay 
The seryl kinase activity of phosphorylase kinase is 
determined by measuring the incorporation of 32p into 
phosphorylase b as described with some modification (18). 
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The standard assay contained 50 mM Tris, 50 mM PIPES, pH 8.2, 
10 mM Mg+2, 10 mg/ml phosphorylase b, and 1 mM [g-32p]_ATP. 
The final concentration of truncated y is adjusted to around 
0.3 nM. The reaction is carried out at 30°C and initiated by 
adding enzyme solution. After incubation a portion of 
reaction mixture is spotted on a square ET-31 filter paper, 
washed with trichloroacetic acid and analyzed by liquid 
scintillation counting (22). The tyrosine kinase activity is 
assayed using angiotensin II as a substrate. The reaction is 
performed in an assay mixture containing 10% glycerol, 50 mM 
Tris, 50 mM PIPES, pH 7.9, 3 mM MnCl2, 2.5 mM angiotensin II, 
and 1 mM [y-32p]-ATP. The final concentrations of the 
truncated y subunit and phosphorylase kinase were 10 and 100 
|j,g/ml, respectively. The tyrosine kinase assay is allowed to 
proceed at 30°C for 30 min. After incubation, a portion of 
reaction mixture is spotted on the phosphocellulose paper and 
washed with cold 0.5% phosphoric acid. When using 
poly(Glu,Tyr) as substrate, the reaction mixture is handled 
as the serine kinase assay. 
Oxidation 
The truncated y subunit is oxidized as essentially 
described by Landgraf et al. (23). To remove DTT, the 
truncated y subunit is dialyzed against R buffer (10% 
glycerol, 50 mM Tris, 50 mM HEPES, 50 mM NaCl, pH 7.8) on 
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Microdialyzer 500 (Bio-Rad) in the cold room for at least two 
buffer changes. The oxidation is carried out at room 
temperature in R buffer containing 0.1 mg/ml truncated g and 
an appropriate amount of Cu2+ (0.5 to 16 |iM) for 20 min. 
After incubation, the oxidized truncated y subunits are 
subjected to seryl and tyrosyl kinases assay. 
Oliaonucleotide-directed site-specific mutagenesis 
Mutagenesis is performed using an Amersham commercial kit 
as described previously (18). Mutation is identified by 
restriction enzyme analysis and verified by sequencing. 
Data analysis 
The kinetic data are analyzed with computer software 
Enzfitter (Elsevier Science Publishers). 
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RESULTS AND DISCUSSION 
Phosphorylase kinase holoenzyme purified from rabbit 
skeletal muscle shows significant tyrosine kinase activity 
with angiotensin II in the presence of Mn2+ but not with Mg2+ 
(Figure 1), Poly(Glu,Tyr) and Raytide, two other common 
tyrosine protein kinase substrates with poly-negative charge, 
can be phosphorylated at a very low level. The tyrosine 
kinase activity of holoenzyme is affected little by 2 mM 
EGTA, a concentration that completely inhibits seryl 
phosphorylation, (Figure 1) suggesting that Ca2+ was not 
essential for tyrosyl phosphorylation. 
Autophosphorylation on a and P subunits of phosphorylase 
kinase is known to activate the enzyme (24-26) . To determine 
whether preincubation of the enzyme with Ca2+, Mg2+, and ATP, 
a condition which causes autophosphorylation, can also 
activate its tyrosine kinase activity, the holoenzyme is 
first treated with the above reagents and then assayed for 
tyrosine kinase activity. Note that if the enzyme is not 
preincubated, there is a lag in the reaction (Figure 2). 
After preincubation, the lag disappears and activity 
increases about 8- to 20-fold in the early stage of time 
course (5-20 min) . Phosphorylation of a and (3 subunits 
occurs as assessed by SDS-PAGE under these conditions 
Figure 1. Tyrosine kinase activity of phosphorylase 
kinase holoenzyme in the presence or absence 
of calcium. The tyrosine kinase activity is 
determined in the presence of Mg2+ (filled 
bars) or Mn2+ (dashed bars) and in the 
presence or absence of Ca2+. The tyrosine 
kinase activity assay is essentially as 
described in Experimental procedures. 
Phosphorylase kinase holoenzyme 100 |J.g/ml is 
incubated with 50 mM Tris, 50 mM PIPES, pH 
7.9, 10% glycerol, 3 mM MnCl2 or MgCl2, 1 mM 
[y-32p]-ATP, 2 mM angiotensin II, in the 
presence of 0.1 mM Ca2+ or 2 mM EGTA, at 30°C 
for 30 min. 
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Figure 2. Effect of preincubation on tyrosine kinase 
activity. The tyrosine kinase activity of 
holoenzyme is determined with (-•-) or without 
(-0-) preincubation. Prior to tyrosine kinase 
assay, phosphorylase kinase 1 mg/ml in R 
Buffer is preincubated with 0.1 mM Ca2+, 3 mM 
MgCl2/ and 1 mM ATP, at 30°C for 30 min. 
After preincubation, one part of enzyme 
solution is mixed with nine parts of substrate 
mixture containing 56 mM Tris, 56 mM PIPES, pH 
7.9, 10 % glycerol, 3.3 mM MnCl2, 2.8 mM 
angiotensin II, and 1.1 mM [7-^2?]-ATP and 
incubated at 30°C for 5, 20, and 50 min. 
Phosphorylase kinase preincubates at 30°C 
without MgATP is used as the control. The 
substrate mixture for control experiment is 
about the same as above except 0.3 mM Mg2+, 
0.1 mM ATP, and 10 mM Ca2+ were added along 
with 3.3 mM Mn2+ and 1.1 mM [y-^Spj-ATP. 
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(result not shown). After approximately 50 min the tyrosine 
kinase activities are similar with or without preincubation. 
To investigate the tyrosine kinase activity of 
phosphorylase kinase more fully, a recombinant truncated form 
of catalytic subunit (1-300) of phosphorylase kinase was 
used. Any contamination of a bacterial tyrosine protein 
kinase in truncated y preparation is excluded by the fact that 
recombinant protein is renatured and purified to homogeneity 
as judged by SDS-PAGE (18). The recombinant truncated y 
subunit also phosphorylates angiotensin II. Mn2+ is required 
for the tyrosine kinase activity, although Co2+ can also 
stimulate a moderate (about 25% of tyrosine kinase activity 
with Mn2+) activity. In contrast, a little tyrosine kinase 
activity (1-5%) can be seen by using Mg2+ alone. These 
results are consistent with the observation that most 
tyrosine kinases prefer Mn+2 more than Mg2+ for their activity 
(8). Poly(Glu,Tyr) and Raytide are poor substrates for 
truncated y. It is reasonable to suggest that both 
angiotensin II and phosphorylase can be recognized by a 
common set of determinants and hence a common active site 
because angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) 
shows some similarity in primary sequence to that of 
phosphorylase (Argi°-Lys-Gln-Ile-£sr-Val-Arg-Gly-Leui^) . 
It has been demonstrated that the serine/threonine kinase 
activity of the truncated y subunit can be inhibited by the 
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oxidation of Cu2+ (27). The oxidation causes the formation 
of two pairs of disulfide bonds in or near the active site 
region and inactivated the conversion of phosphorylase b to a 
by interfering with the binding of substrates. If both 
serine/threonine and tyrosine kinase activities of 
phosphorylase kinase share the same active site in the y 
subunit, oxidation should interfere with the binding of both 
substrates. As shown in Figure 3, both serine/threonine and 
tyrosine kinase activities of the truncated y subunit are 
inhibited identically with increasing Cu2+. The idea of two 
kinase activities sharing one active site is further 
supported by result of site-directed mutagenesis at an 
invariant residue of the catalytic loop, Asp^^° corresponding 
to Asp^®^, the putative catalytic base, of cAMP-dependent 
protein kinase (28). A similar but uncharged residure, Asn, 
was used to replace Asp^^o in y. The mutant is constructed, 
expressed, and purified to homogeneity. Both 
serine/threonine and tyrosine kinase activities are abolished 
by this mutagenesis. 
The influence of metal ions on the substrate specificity 
of the truncated y subunit of phosphorylase kinase is shown in 
Figure 4. Inhibition of serine/ threonine kinase activity 
and activation of tyrosine kinase activity of truncated y show 
parallel changes by increasing Mn2+ in the presence of 
equivalent amount of Mg2+ and ATP. The two activity curves 
Figure 3. Oxidation inhibits both serine/threonine and 
tyrosine kinase activities. The inhibition 
curves for serine/threonine kinase (-•-) and 
tyrosine kinase (-0-) are presented. 
Oxidation of truncated y is carried out as 
described in Experimental Procedures. After 
oxidation the truncated y subunit is diluted 
to an appropriate concentration with R buffer 
and subjected to serine kinase and tyrosine 
kinase assay. 
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Figure 4. Manganese induces parallel changes in 
serine/threonine and tyrosine kinase 
activities of the truncated y subunit. The 
serine/threonine kinase activity (-0-) and 
tyrosine kinase activity (-•-) is measured 
with increasing Mn2+. The assays are done as 
essentially described in Experimental 
Procedures except that 3 mM Mg2+ is added in 
all assay mixtures along with various amounts 
of Mn2+ as indicated. 
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intersect at a concentration of approximately 250 mM Mn^+, 
which is also the EC50 for both curves, suggesting this effect 
is due to the binding of Mn^+ at a common site. The crystal 
structure of cAMP-dependent protein kinase (12) shows that 
the nucleotide binding site is located at the base of the 
small lobe and the second metal ion and peptide substrate are 
mainly situated on the large lobe. The binding of a second 
metal ion, Mg2+ or Mn^+, may hold the nucleotide in the 
active site and cause inhibition (9,29). For phosphorylase 
kinase, the second metal ion, especially Mn^+, may have a 
different role, modulating substrate specificity. Bollen et 
al. (30) suggested that the catalytic subunit of 
phosphorylase kinase might have two active conformations to 
recognize different seryl substrates. Olah et al. (31) 
demonstrated that the large lobe of the catalytic subunit of 
cAMP-dependent protein kinase can rotate about 35 degree 
around a hinge residue, Gly 125, a residue which is invariant 
in protein kinases (32). Lindberg, et al. (4) suggested a 
flexible active site region to explain the dual specificity 
of some kinases. The two metal ions, Mn^+ and Mg2+, could 
stabilize different conformations because of differences in 
their chemical properties and ionic radii. These two metal 
ions interact differently in the nucleotide binding region of 
a mutant nitrogenase (33). 
Table I 
Comparison of Kinetic Parameters of the Truncated y Subunit 
in the presence of Mg2+ or Mn^+ and with Different Substrates 
Substrates 
Mg2+# Mn2 + 
Km Vm 
{ninol/rain y nmol ) 
Km Vm 
{nmol/itiin/nmol ) 
ATP (MM) 
Phos b (nM) 
Angiotensin 
(iriM) 
79 ± 10 
4100 ± 30 
18 ± 1 
ND ND 
54 ± 3 
163 ± 8® 
4 . 0  ±  0 . 2 ®  
4 . 4  ± 0 . 2  0 . 4 7  ± 0 . 0 2  
# see ref 18. 
® Apparent Km and Vm were obtained from the mean value of 
three different experiments. 
ND= not determined. 
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Kinetic results (Table I) show that in the presence of 
Mn2+ the Km for ATP (54 ± 3 |IM) is about the same as that 
measured in the presence of Mg2+ (79 jiM) (18) . The apparent 
Km for phosphorylase b (4.0 ± 0.2 |IM), however, is about 5-
fold lower. In the presence of Mg2+ the tyrosine kinase 
activity is almost non-detectable. The Vm and Km are 0.47 ± 
0.02 nmol/min/nmol and 4.4 ± 0.2 mM, respectively, using 
angiotensin II as substrate in the presence of Mn2+. This 
result suggests that a conformational change at active site 
region caused by the binding of Mn2+ may further expose the 
binding site to its substrate and gives more room for a 
phenolic group. It is known that the binding of second metal 
ion can increase the affinity of enzyme for its substrate 
with the insulin receptor tyrosine kinase (34). A 
conformational change in g induced by Mn2+ may turn the 
alcoholic group of Ser^^ of phosphorylase h away from the 
putative catalytic base, Asp^^®, and reduce the rate of 
phosphoryl transfer (apparent Vm=163 ± 8 nmol/min/nmol)(Table 
1) . The tyrosine kinase activity of truncated y is similar to 
that of most tyrosine kinases. When compared with its serine 
kinase , the tyrosine kinase activity is about 1/350 of its 
serine kinase activity using MnATP as substrate (Table I). 
This result is consistent with the general observation that 
turnover rates of tyrosine protein kinases are usually 
several orders lower than that of serine/threonine kinases. 
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So far, at least 11 dual specificity kinases have been 
reported (4). Most of these enzymes, however, have been 
identified from autophosphorylation reactions targeting 
tyrosine and serine/ threonine residues or from reactivity 
with anti-phosphotyrosine antibodies after expression in 
bacteria. Some dual-specificity kinases have been reported 
to phosphorylate exogenous substrates (5-7,35, 36) and have a 
role in cell development. The results presented herein show 
that phosphorylase kinase has dual specificity but whether 
this new activity is physiologically significant remains to 
be determined. 
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ABSTRACT 
The truncated form of the y subunit of phosphorylase 
kinase is found to be inactivated by pM amounts of Cu^+. The 
inactivation of truncated y can be readily reversed by DTT but 
not by the metal chelating agents, EDTA or EGTA. This result 
suggests that inactivation is caused by disulfide bond 
formation. Maximally two intramolecular disulfide bonds are 
formed by the oxidation of Cu2+ as determined by DTNB 
titration and non-reducing SDS-polyacrylamide gel 
electrophoresis. The formation of the first disulfide bond, 
denoted as the semi-oxidized form, results in 50% loss of 
specific activity. Kinetic study of the semi-oxidized form 
of truncated y shows that Vm (3,4 + 0.4 |imol/min/nmol) and Km 
for phosphorylase h (18.0 ± 0.2 |XM) are similar to those of 
the reduced form. However, the Km for MgATP (780 ± 50 (iM) is 
about 10-fold higher. This result suggests that the first 
disulfide bond may be in or near by the nucleotide binding 
domain of the truncated y. This speculation is further 
supported by the localization of the first disulfide bond 
(between Cys-36 and Cys-172) by peptide mapping and amino 
acid sequencing. 
The truncated y subunit can also be inactivated by the 
disulfide form of a peptide analog of the phosphorylation 
site in glycogen phosphorylase, containing cysteine instead 
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of serine, through thiol/disulfide exchange. This is proved 
by the fact that inactivation can be reversed by DTT. The 
kinetic study suggests that inactivation is not due to 
blocking of the active site because Km values of Cys-peptide 
coupled truncated y for ATP (143 ± 16 |JM) and phosphorylase h 
(39 ± 2 |IM) are only about 2-fold higher than those of 
reduced form. This result is consistent with the finding 
that Cys-138 is the site cross-linked to the Cys-peptide. 
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INTRODUCTION 
Phosphorylase kinase plays a crucial role in the 
regulatory cascade of glycogen metabolism (1-3). It 
activates phosphorylase and facilitates the breakdown of 
glycogen by transferring the y-phosphate of ATP to the 
alcoholic group of serine-14 of phosphorylase. Phosphorylase 
kinase contains four different subunits, a, P, y, and 5 with a 
stoichiometry of (aPy5)4 (4). The a and p subunits are 
regulatory subunits (5-7), and Ô is almost identical to 
bovine brain calmodulin (8). The y subunit has been 
demonstrated to be the catalytic subunit (9,10) containing a 
kinase domain (11) and a calmodulin (CaM) or the 5 subunit 
binding domain (12). 
The crystal structure of the y subunit of phosphorylase 
kinase is not known so far. However, the primary sequence of 
the catalytic domain of y is highly homologous to cAPK and 
other kinases (11). Accordingly, the catalytic domain of y 
likely shares some structural features with those in cAPK 
(13-16) . Several conserved sequences in kinases have been 
speculated to be either directly contacting substrates or 
important for the active site configuration (16) . Among 
these conserved sequences none are cysteine residues. 
However, several pieces of evidence have suggested that 
sulfhydryl groups may be directly or indirectly involved in 
48 
the regulation and/or substrate recognition in the kinase 
family. Cys-199 in the C subunit of cAPK is at the edge of 
the active site region (13,14) and provides a general 
hydrophobic environment to the P+1 site of the substrate. In 
addition, this residue has been shown to cross-link with Cys-
97 of the Rii subunit in vitro through a disulfide bond (17). 
Cys-518, corresponding to Cys-199 of cAPK, in the catalytic 
domain of cGMP-dependent protein kinase (cGPK) was found to 
form a disulfide bridge with Cys-312 and induced a cGMP-
independent kinase activity (18). A similar result was 
obtained with protein kinase C when it was oxidized with H2O2 
(19). A Ca2+/phospholipid-independent activity was induced 
after oxidation. In the case of CaM-dependent protein kinase 
II, the modification of cysteine residues by N-ethylmaleimide 
and DTNB inactivated the kinase activity (20). The 
inactivation, however, could be eliminated by ADP but not by 
peptide substrate, Ca^+-CaM, or phosphorylation. 
The Y subunit of phosphorylase kinase has seven sulfhydryl 
groups, one in the CaM binding domain and six in the 
catalytic domain. According to the crystal structure of cAPK 
(13,14) four out of seven cysteine residues, 36, 172, 184, 
and 197, are suggested to be in or near the active site 
region of y. The Cys-184 is conserved among several kinases 
including cAPK (Cys-199), cGPK (Cys-512), and protein kinase 
C (11). Recently, a truncated y subunit (1-300) without the 
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C-terminal CaM binding domain, denoted as TR-y, was 
constructed (21) in our laboratory. The usage of TR-y allows 
us to characterize the functions of sulfhydryl groups more 
fully without the influence of the CaM binding domain and to 
gain information about the proximity of the SH groups of the 
enzyme in aqueous solution. In this paper we present a 
series of experiments showing that the catalytic subunit of 
phosphorylase kinase can be inactivated reversibly by the 
formation of a disulfide bond in the active site region. 
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EXPERIMENTAL PROCEDURES 
Materials 
The recombinant truncated y subunit (1-300) of 
phosphorylase kinase was expressed, renatured, and purified 
as described previously (21). Renatured TR-y was stored at 
0°C in R Buffer (10% glycerol, 50 mM Tris-HCl, 50 mM HEPES, 
pH 7.8, 50 mM NaCl) containing 5 mM DTT. Phosphorylase b was 
prepared as described (22). A Cys-peptide (LysArgLysGlnlle-
CvsValAraGlvLeu) was synthesized by the Protein facility at 
Iowa State University with an Applied Biosystems 430A peptide 
synthesizer. [y-32p]atp was obtained from ICN. Dimethy1-
aminoazobenzene iodoacetamide (DABIA) was from Fluka 
Chemical. Econo Pac-IODG gel filtration column and Bio-Gel 
P-6 resin (50-100 mesh) were from Bio Rad. Iodoacetamide and 
glutathione disulfide were obtained from Sigma. DTNB was 
from Pierce. All other reagents were reagent grade. 
Oxidation of the truncated y subunit bv copper ion 
The oxidation of the truncated y subunit of phosphorylase 
kinase is essentially as described by Yuan, et al. (23) with 
some modification. The renatured, purified TR-y was first 
passed through an Econo Pac-IODG gel filtration column 
equilibrated with R Buffer to remove DTT. The enzyme (0.2 
mg/ml, at pH 7.8) was then oxidized by incubation with 
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various amounts of CUCI2 (0.5 to 20 ^iM) at room temperature 
for around 20 min. After incubation, the oxidized TR-y was 
diluted with R Buffer if necessary and assayed for enzymatic 
activity. The oxidized TR-y subunit could be reactivated by 
treating with DTT. After incubating with Cu^+, 10 |ll of the 
protein mixture was mixed with an equal volume of R Buffer 
containing 50 mM DTT, and 1 mM EDTA. The whole mixture was 
then incubated on ice for 9 h after which enzymatic activity 
was measured. 
DTNB titration 
Sulfhydryl groups of the reduced and oxidized TR-y subunit 
were determined by DTNB titration (24). The titration was 
carried out by dissolving solid urea in 190 Hi of protein 
solution (0.2 mg/ml) with or without Cu2+ treatment and 0.4 M 
Na2HP04, pH 8.0 to give a total volume of 400 jil. The final 
concentration of urea and phosphate was 6 M and 100 mM, 
respectively. The reaction was initiated by adding 15 |Xl of 
freshly prepared 20 mM DTNB. The mixture was incubated at 
room temperature for 15 min before measuring the absorbance 
at 414 nm. The concentration of sulfhydryl groups was 
calculated using 6^24 = 13,600 M-^cm"^ (24). 
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Coupling of Cvs-peptide to the truncated y subunit 
The Cys-peptide dimer, a peptide analog to the 
phosphorylation site sequence of glycogen phosphorylase, was 
prepared by incubating the peptide solution at 30 °C in the 
absence of reducing agent for 24 h or longer. The 
dimerization of the Cys-peptide was checked by DTNB 
titration. The TR-y solution, free of DTT, (0.2 mg/ml) was 
incubated with appropriate amounts of Cys-peptide dimer in R 
Buffer at room temperature for 20 min. 
Activity assay 
The serine kinase activity of reduced and oxidized TR-y 
was determined by the incorporation of 32p into phosphorylase 
b. The assay was performed at pH 8.2 in the presence of 50 
mM Tris-HCl, 60 mM HEPES, 10 mM MgCl2, 1 mM [y-^^pj^TP, and 
100 |IM phosphorylase b. The final concentration of the 
reduced and oxidized TR-y subunit was adjusted to about 0.6 
nM. After incubating the reaction mixture at 30°C for 5 min 
an aliquot was removed, spotted onto a square ET-31 paper 
(Whatman), and washed with trichloroacetic acid and analyzed 
by liquid scintillation counting (25). 
Labeling of sulfhvdrvl groups with DABIA 
After DTT was removed, the TR-y subunit (around 1 mg) was 
oxidized with 4 |IM Cu2+ (semi-oxidized) or 0.5 mM Cys-peptide 
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dimer as described previously. The labeling of the remaining 
free sulfhydryl groups follows and is based on modified 
procedures of Lewis et al. (26) and Landgraf et al. (18). 
The protein treated with Cu^+ or Cys-peptide was first mixed 
with solid iodoacetamide to 100 mM followed by the addition 
of solid urea to 6 M. The sample was allowed to incubate at 
37 °C in the dark for 1 h before precipitating protein with 
20% TCA. The precipitate was spun down and pellet was washed 
twice with cold acetone. The pellet was air dried and 
dissolved in 150 |ll 5 M guanidine-HCl, 50 mM Tris, 5 mM EDTA, 
pH 8.0, and 1 mM DTT. The mixture was incubated under N2 in 
the dark at 37 °C for 2 h. This cleaves the disulfide bonds 
formed in the reaction with Cu2+ or the Cys-peptide dimer. 
After incubation, the free thiols generated from the 
disulfides were labeled with DABIA (18,27). The reaction was 
carried out by mixing the above solution with one volume of 5 
M guanidine-HCl, containing 50 mM Tris, pH 8.0, and 5 mM EDTA 
and two volumes of DABIA (1 mg/ml in dimethylformamide) . The 
samples were incubated at room temperature in the dark for 2 
h with stirring. The mixture was acidified by adding 10 fll 
of TFA and loaded onto a Bio-Gel P-6 column (1,2 x 15 cm) 
pre-equilibrated with 50% acetic acid. The protein was 
eluted with 50% acetic acid. Labeled protein containing 
DABIA was identified by following the absorbance at 540 nm of 
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the collected fractions. The pooled fractions were then 
dried using a SpeedVac (Savant). 
Proteolysis. HPLC purification, and sequence analysis 
The DABIA-labeled semi-oxidized (0.8 mg) and Cys-peptide 
coupled (0.8 mg) TR-y subunit s were suspended in 600 |il 0.1 M 
NH4CO3, pH 8.3. Labeled proteins were then digested with 2-4% 
TPCK-trypsin (w/w) at 37 °C for 20 h. An additional amount 
of trypsin was added after 4 h incubation. The peptide 
mapping of tryptic peptides was performed on a reverse-phase 
C18 column (4.6 X 250 mm, Vydac) with 0.1% TFA in H2O as 
Buffer A, 0.08% TFA in acetonitrile as Buffer B, and at a 
flow rate of 1 ml/min. The DABIA-labeled peptides were 
isolated using a linear gradient from 20 to 40% Buffer B in 
40 min. Modified peptides containing the DABIA group were 
detected by simultaneously monitoring the eluant at 215 and 
540 nm. The DABIA-labeled peptides were pooled and re­
injected onto a reverse-phase Cis column for further 
purification. The purified peptides were submitted to the 
Protein Facility at Iowa State University for sequencing with 
an Applied Biosystems All A automated amino acid sequencer. 
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Data analysis 
Data obtained from the kinetic studies were analyzed with 
the Enzfitter computer software program (Elsevier Science 
Publishers), 
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RESULTS 
Reversible inactivation of truncated y with Cu2± 
The divalent transition metal ion, Cu2+, is used as a 
mild oxidizing reagent because of its positive redox 
potential (18). As shown in Figure 1 the TR-y subunit of 
phosphorylase kinase can be inactivated by Cu2+ at pH 7.8 in 
a range of 1 to 20 |iM with an IC50 of around 4 |1M. The 
inactivation of TR-y is partially protected by MgATP but not 
by protein substrate, Mg2+, or ATP at low concentration of 
Cu2+ (data not shown). At a high concentration of Cu2+, 
however, inactivation still occurs with or without ligands. 
The inactivation effect of Cu2+ on TR-y is reversible when 
treated with DTT (Figure 2). In contrast, the chelating 
agents, EDTA or EGTA, do not reverse the inactivation (data 
not shown). These results suggest that the inactivation of 
the enzyme is likely caused by the formation of a disulfide 
bond but not by a thiol-metal linkage. Non-reducing SDS-
polyacrylamide gel electrophoresis shows that no dimeric or 
heavier forms of TR-y can be detected after reaction with Cu2 + 
(Figure 3). This suggests that if cross linking has 
occurred, as presumed, the reaction occurs through the 
formation of an intra- but not inter-molecular linkage. 
Figure 1. Inactivation of truncated-y with various 
amounts of Cu^+. The oxidation of truncated-y 
by Cu2+ (0.5 to 20 pM) is as described in 
Experimental Procedures. After oxidation 
the truncated y was diluted for serine kinase 
assay. 
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Figure 2. Reversal of the inactivation of the truncated 
7 subunit by treatment with DTT. The 
oxidation and reactivation of the truncated y 
subunit are as described in Experimental 
Procedures. 
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Figure 3. Non-reducing SDS-polyacrylamide gel 
electrophoresis of the truncated y subunit 
with or without the treatment of Cu2+. 
Truncated y was oxidized with the indicated 
amounts of Cu2+ at room temperature for 20 
min. lodoacetamide (50 mM) was added 20 min 
before electrophoresis to prevent any 
disulfide exchange. Samples were 
electrophorsed with a 12.5% non-reducing SDS-
polyacrylamide gel. Approximately 5 |lg 
protein was used per lane. Molecular weight 
markers used from the top are: phosphorylase b 
(97,500), bovine serum albumin (66,200), 
ovalbumin (45,000), carbonic anhydrase 
(31,000), trypsin soybean inhibitor (20,500), 
and lysozyme (14,500). 
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Determination of free sulfhvdrvl groups 
The TR-Y subunit of phosphorylase kinase contains 6 
cysteines/molecule (11,28). Titration of -SH groups in the 
reduced TR-y subunit with DTNB yields 5.8 ± 0.2 SH groups/ 
molecule in the presence of 6 M urea (Table I) and 3.9 ± 0.2 
without urea (data not shown). This observation suggests 
that two cysteines are buried and inaccessible to DTNB. As 
shown in Table I the serine kinase activity of the enzyme 
decreases along with the decrease in SH groups/molecule. 
When TR-Y is incubated with low concentration of Cu^+ (2 and 4 
IJM) there is one disulfide bond formed as determined by the 
DTNB titration (3.9 ± 0.1 and 3.6 ± 0.4 SH groups/molecule, 
respectively, Table I). The serine kinase activity of the 
enzyme is also inactivated to around 78 ± 1 % and 52 ± 4 %, 
respectively, compared with that of reduced enzyme. At 
higher concentration of Cu^+ (7 and 10 |iM) however, two 
disulfide bonds are formed as demonstrated by the yields of 
2.3 ± 0.2 and 2.1 ± 0.3 SH groups/molecule, respectively. No 
further change in the number of titratable sulfhydryl groups 
is found with higher concentrations of Cu2+. These result's 
provided evidence for the view that the inactivation of 
phosphorylase kinase is caused by the formation of disulfide 
linkages. The TR-y subunit oxidized by 4 (IM Cu^+ is denoted 
as "semi-oxidized" and used for further characterization. 
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Table I 
Inactivation of truncated y and DTNB titration § 
[Cu2+] , nM % Activity -SH groups/molecule 
0 100 ± 2 5.8 ± 0.2 
2 78 ± 1 3.9 ± 0.1 
4 52 ± 4 3.6 ± 0.4 
7 30 ± 6 2.3 ± 0.2 
10 10 ± 2 2.1 ± 0.3 
@ The truncated y subunit is preincubated with Cu^+ as 
indicated. All titrations are performed in the presence 
of 6 M urea as described in Experimental Procedures . 
The activity of reduced and oxidized kinase is assayed in 
the absence of DTT at pH 8.2. The values are means ± S.E. 
from two independent experiments. 
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Characterization of semi-oxidized truncated y 
It has been suggested that the inactivation of TR-y 
subunit is caused by the formation of disulfide bond. 
However, why this causes inactivation is unclear. Because 
MgATP can protect the enzyme from oxidation with a low 
concentration of Cu^+, the involvement of cysteine residues 
in the nucleotide binding region is possible. To learn 
whether Cys residues are involved, a semi-oxidized form of 
TR-y was used for kinetic studies. As shown in Figure 4 the 
metal ion response of the serine kinase activity of the semi-
oxidized form is about the same as that of the reduced form 
except that some inhibition is observed with 10 mM or higher 
Mg2+, Because of this slight inhibition, 5 mM Mg2+ was used 
in the kinetic studies of semi-oxidized TR-y. As shown in 
Table II the Km with respect to phosphorylase b of the semi-
oxidized form (18.0 ± 0.2 |iM) is the same as that of the 
reduced form (18 ± 1 |IM) (21) . The Km for ATP (780 ± 50 |IM) , 
however, is about 10-fold higher than that of the reduced one 
(79 ± 10 |J,M) . The Vm of the semi-oxidized form (3.4 ± 0.4 
|iinol/min/nmol) is similar to that of reduced enzyme (4.10 ± 
0.03 Hmol/min/ nmol). This result suggests that there are 
two cysteines near by or in the nucleotide binding site which 
are needed in their free state for optimal binding. 
Table II 
Comparison of Kinetic Parameters of Reduced and Modified 
Truncated y Subunit of Phosphorylase Kinase 
Phos h (MM) ATP (jiM) Vm 
TR-7 Ka Kia Kb Kib (nmol/min/nmol) 
Reduced® 18 ± 1 24 ± 3 79 ± 10 105 ± 21 4.10 ± 0.03 
Semi-Oxidized 18.0 ± 0.2 22.4 ± 0.1 780 ± 50 981 ± 25 3.4 ± 0.5 
Cys-peptide 
Coupled 39 ± 2 37 ± 1 143 ± 16 135 ± 7 1.5 ± 0.2 
@ See Huang, C.-Y. F. et al. (1993) Mol. Cell. Biochem. (in press). 
Figure 4. Metal ion response of the reduced and semi-
oxidized truncated y subunit. (A) Reduced 
form of truncated-y. (B) Semi-oxidized form 
of truncated y was prepared by incubating with 
4 (iM of Cu2+ as described in Experimental 
Procedures. Metal ion response curves are 
done by determining serine kinase activity of 
truncated y in the presence of 0.2 mM [y-32p] _ 
ATP and various amount of Mg2+ (-•-) or 
Mn2+ (-0-) as indicated. 
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Inactivation of truncated y with Cvs-peptide dimer 
The Cys-peptide was synthesized according to the 
phosphorylation site sequence of phosphorylase b 
(^LysArgLysGlnlleSÊEValArgGlyLeu^®) with cysteine instead of 
serine at the phosphorylation site. This peptide is not a 
substrate of phosphorylase kinase. The SH group of Cys-
peptide can be easily oxidized and cross-linked to the thiol 
group of the second Cys-peptide, termed Cys-peptide dimer, in 
the absence of DTT. As shown in Figure 5 about 90% of serine 
kinase activity of the enzyme is lost upon the incubation of 
the enzyme with the Cys-peptide dimer. No inactivation 
occurred if DTT was present during incubation. The 
inactivation can easily be reversed by treatment with 50 mM 
DTT (Figure 6) suggesting a thiol/disulfide exchange has 
occurred between the Cys-peptide dimer and protein. To 
evaluate the mechanism of inactivation by the Cys-peptide, 
the kinetic parameters of the kinase reaction catalyzed by 
Cys-peptide-coupled TR-y was studied (Table II) . The Ka for 
phosphorylase b and Kb for ATP (39 ± 2 and 143 ± 16 |LIM, 
respectively) were around 2-fold higher than those of wild 
type TR-y. The Vm, however, is about 7-fold lower (0.60 ± 
0.07 nmol/min/nmol). These results suggest that the thiol 
group coupled with Cys-peptide is not crucial for binding of 
either substrate. The SH group might not even be in the 
active site. However, the coupling of Cys-peptide to TR-y 
Figure 5. The inactivation of the truncated y subunit by 
a Cys-peptide dimer. Cys-peptide dimer is 
prepared by incubating peptide solution at 
30 °C under air for around 24 h. The 
dimerization of Cys-peptide was confirmed by 
DTNB titration. The DTT-free truncated y 
subunit (0.1 mg/ml) is incubated with 0.5 mM 
Cys-peptide dimer at pH 7.8 in the presence or 
absence of 1 mM DTT at room temperature for 
approximately 20 min. The serine kinase assay 
is then carried out as described in 
Experimental Procedures. 
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Figure 6. Reactivation of Cys-peptide coupled truncated 
Y by DTT. The reactivation of Cys-peptide 
coupled truncated y' s is carried out by mixing 
equal volume of Cys-peptide coupled truncated 
Y with 10 mM DTT on ice for 1 hr. Activity is 
measured as described in Experimental 
Procedures. 
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Figure 7 . The pH curves of reduced and Cys-peptide 
coupled truncated y. The pH-dependent curves 
of reduced (-A-)  and Cys-peptide-coupled 
(-0-) truncated y was done by assaying the 
serine kinase activity under various pH (6.1 
to 9.0). The activity assay is performed as 
described in Experimental Procedures. 
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could restrict the conformational change of TR-y to its 
optimal form. This speculation is suggested by results of 
the pH activity curves of the reduced and Cys-peptide coupled 
TR-y subunit (Figure 7). The Cys-peptide-coupled TR-y subunit 
shows a distinct pH curve from that of reduced TR-y. The 
change of the pH curve in Cys-peptide-coupled TR-y suggests 
that the environment of its catalytic base is different from 
that of the reduced form. To evaluate whether the effect is 
specific for the phosphorylase b sequence, the TR-y was 
incubated with another disulfide peptide, glutathione 
disulfide. In contrast, glutathione disulfide did not 
inhibit the enzymatic activity of DTT-free TR-y (data not 
shown). 
Identification of -SH groups in truncated y involved in 
oxidation and Cvs-peotide coupling 
The previous results suggest that the formation of 
intramolecular disulfide bonds in or near the active site 
region inhibits kinase activity. The location of these 
sulfhydryl groups involved in cross-linking reactions may 
help us to understand the conformation of the active site 
region of y and facilitate the comparison with the 3D 
structure of cAPK (13-16). To identify the cysteinyl 
residues involved in disulfide bond formation, DABIA was 
used. DABIA has been demonstrated to be useful in labeling 
77 
and identification of cysteinyl containing peptides (18,27). 
However, to trap faithfully the original disulfides it is 
important to prevent thiol/disulfide exchange reactions, 
especially in the presence of strong dénaturants, urea and 
guanidine HCl (29). Scheme I outlines the procedures we used 
to identify the vicinal sulfhydryl groups in TR-y. After 
incubating with Cu2+ or Cys-peptide dimer the remaining free 
-SH groups in TR-y are quenched by alkylation with excess 
amounts of iodoacetamide to eliminate any thiol/disulfide 
exchange. The alkylation is terminated by precipitating 
modified protein with 20% TCA. The protein pellet is, then, 
re-dissolved and treated with DTT at pH 8.0. The disulfide 
bond is reduced in this stage and newly formed free SH groups 
are ready for labeling with DABIA . 
The isolation of DABIA-labeled peptide can easily be 
followed by monitoring the absorbance at 540 nm as shown in 
Figure 8. A tryptic digestion of both Cys-peptide coupled 
TR-yand the semi-oxidized TR-y subunit yield two major peaks 
(C-1, C-2, S-1 and, S-2; Figure 8), respectively. The 
corresponding peptide sequences are shown in Table III. The 
Cys-13 8 forms a disulfide bond with Cys-peptide. This result 
along with the kinetic results suggests that a cysteinyl 
outside of active site region might be involved in cross-
linking with Cys-peptide. 
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Figure 8. Peptide mapping of the tryptic DABIA-labeled 
truncated y subunit. (A) Cys-peptide coupled 
truncated y. (B) Semi-oxidized form of 
truncated y. Separation of DABIA-labeled 
peptides is performed as described in 
Experimental Procedures. The elution profile 
is monitored at 540 nm. 
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Table III 
Sequences of DABIA-labeled Cys containing peptides from 
semi-oxidized and C-peptide coupled TR-y 
Peptide Sequence 
C-1® 12Q_I_£_V-R16 
C-2 132A-L-L-E-V-I-£,-A-L-H-K142 
S-1 36£_I_H-K39 
S-2 165L_T-D-F-G-F-S-£-Q-L-D-P-G-E-K179 
® Peptide C-1 is from Cys-peptide.(®K-R-K-Q-I-£-V-R-G-L1^) 
of phosphorylase. 
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The first disulfide bond is formed between Cys-36 and 
Cys-172 (Table III). Both thiols are in the active site 
region of TR-y and close to the nucleotide binding domain as 
predicted by the 3D structure of CAPK (13-16). This result 
is consistent with the kinetic study of the semi-oxidized TR-y 
subunit (Table I). The nucleotide binding site could be 
shielded by the formation of a disulfide bond between Cys-36 
and Cys-172. This result may explain the high Km value of 
the semi-oxidized TR-y for ATP. However, the possibility that 
both or one of these two thiols are involved in the 
recognition and binding of the nucleotide substrate can not 
be ruled out. 
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DISCUSSION 
The transition metal ion, Cu2+, an oxidizing agent, has 
been demonstrated by this work and other studies (18) to be 
useful for promoting disulfide reactions between neighboring 
thiol groups. The oxidation by Cu2+ results in the loss of 
activity of TR-y. The reducing reagent, DTT, but not metal 
chelating reagents, EDTA and EGTA, reverse the inactivation 
effect of Cu2+ on the TR-y subunit suggesting that 
inactivation is caused by the formation of -S-S- bridge (s). 
DTNB titrations of reduced and Cu2+ oxidized TR-y indicates 
that four out of six free sulfhydryl groups are involved in 
the disulfide bonds formation (Table I). These four free 
thiols formed two intra- but not inter-molecular disulfide 
bonds demonstrated by the fact that the reduced and oxidized 
truncated y subunit migrate the same distance on a non-
reducing SDS-polyacrylamide gel. The oxidation inhibits the 
activity of TR-y suggesting that these free thiols may be in 
or near the active site region of the catalytic subunit of 
phosphorylase kinase and must be spatially close. 
According to the crystal structure of cAPK (13,14) and 
primary sequence alignment (11) four free sulfhydryl groups, 
Cys-3 6, Cys-172, Cys-184 and Cys-197, which are likely for 
Cu2+ oxidation and disulfide formation. Among these free 
thiols Cys-36 and Cys-172 are close to the nucleotide binding 
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site and have been demonstrated to be one vicinal thiols 
pair. Although the second disulfide bond has not been solved 
in this study, Cys-184 and Cys-197 are expected to be the 
candidates based on studies of the Cys-mutants (30). No 
other SH groups could be expected to be spatially close based 
on the 3D structure of cAPK (13-16). 
Recently, a flexible active site region of cAPK has been 
demonstrated by several studies (31-33). The small lobe of 
cAPK can rotate 15-39° relative to the large lobe upon the 
binding of substrates or inhibitors. Without the binding of 
substrate the active site cleft is wide open, termed the open 
structure, and allows substrates free access (31-33). Once 
substrate binds a sort of "induced fit" may occur in the 
active site region and bring those conserved residues in the 
small lobe back to an optimal position, termed the closed 
structure, for interaction with the substrate. This 
conformational change may alter the local structure of the 
catalytic base and, hence, the catalysis of the kinase. The y 
subunit could have a similar flexible structure in the 
absence of substrates. However, the small lobe of y may have 
a larger movement toward the large lobe if a disulfide bond 
is formed between Cys-36 and Cys-172. Accordingly, the 
active site cleft of y between small and large lobes may be 
narrower than that in the crystal structure of cAPK ternary 
complex (8-10), because Cys-36 is located on the small lobe 
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and Cys-172 on the large one. The flexible active site cleft 
can be fixed by the binding of substrates. This speculation 
is supported by the observation that MgATP can partially 
protect TR-y from oxidation by Cu2+. 
Cys-138 in the TR-y subunit must be relatively exposed as 
indicated by the fact that this residue but not others, e.g., 
Cys-184, can be easily cross-linked to Cys-peptide through 
thiol/disulfide exchange. Cys-199 of cAPK, corresponding to 
Cys-184 of Y' has been demonstrated to be the primary target 
of various thiol specific agents and peptide analog (34,35). 
This result is consistent with the observation that Glu-155 
in the E-helix of cAPK, corresponding to Cys-138 of y, is on 
the side facing the acyl-binding pocket and plays a role in 
the interaction with the myristyl group (33,36). This acyl-
binding pocket is surrounded by the A-helix, E-Helix, a loop 
connecting C-helix and P-sheet 4, and part of C-terminal 
tail. In TR-y, however, there is no A-helix and C-terminal 
tail in this region and could make Cys-138 wide open and 
easily accessible for a reaction with the Cys-peptide. The 
myristyl group in cAPK has been suggested to stabilize 
protein structure (33). Meanwhile, the cross-linking of Cys-
peptide to Cys-13 8 of TR-y may provide a steric hindrance and 
restrict the conformational change in the active site region. 
The flexibility in the active site region of the catalytic 
subunit of phosphorylase kinase seems important for its 
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phosphotransferase activity. This speculation is suggested 
by the observation that Cys-peptide-coupled TR-y shows a 
sigmoid pH-activity curve while that for the wild type kinase 
is relatively flat (Figure 7). A higher pKa value for the 
catalytic base in the Cys-peptide coupled TR-y subunit is 
suggested by this result. Accordingly, the environment of 
the catalytic base in Cys-peptide coupled TR-y could become 
more hydrophobic because of the coupling of Cys-peptide. 
Without the restriction provided by the coupled Cys-peptide 
TR-y may adjust its active site region more effectively to an 
optimal conformation to expose its catalytic base as well as 
to accommodate the incoming substrates. 
It is also possible that Cys-138 in y may play a similar 
role by interacting with either regulatory subunit, a or (3, 
or with its C-terminal calmodulin binding domain. The 
interaction of the regulatory subunits or C-terminal 
calmodulin binding domain to this region may regulate the 
phosphotransferase activity of the y subunit. This 
speculation is partly suggested by the results that TR-y has 
higher Vm and lower Km values for both substrates (21) than 
those of various forms of phosphorylase kinase (10,37-39). 
However, further characterizations are needed to determine 
whether this region is involved in the interaction with other 
subunits. 
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ABSTRACT 
To determine the function of each free sulfhydryl group 
in truncated y subunit of phosphorylase kinase all six thiols 
were replaced with serine by site-directed mutagenesis, i.e., 
C36S, C42S, C138S, C172S, C184S, and C197S. In addition, 
C36A mutant was also prepared. After Cu2+ oxidation, DTNB 
titration indicated that the number of free sulfhydryl groups 
of all but C42S and C138S mutants was decreasing by two. 
These results suggest that Cys-36, -172, -184, and -197 are 
involved in the formation of disulfide bonds in wild type 
truncated y by the oxidation with Cu2+. All mutants except 
C3 6S and C184S show normal serine and tyrosine kinase 
activities. The kinetic studies show that C3 6S has a similar 
Km for phosphorylase b but its Km for ATP is about 2-fold 
higher. The Vm, however, is about 8-fold lower than that of 
wild type truncated y. These results suggest that Cys-36 may 
not be directly involved in the binding of ATP or 
phosphorylase b- This mutation also reduces tyrosine kinase 
activity greatly. The mutant C184S is particular interesting 
because tyrosine kinase activity is affected much more by 
this mutation than is the serine kinase activity. The 
tyrosine kinase activity of C184S is about 20-fold lower by 
comparison with wild type truncated y. C184S and wild type 
truncated y have similar Vm values and Km's for ATP. The Km 
94 
with respect to phosphorylase b of C184S, however, increased 
about 3-fold compared to that of wild type truncated y. In 
the presence of Mn2+ angiotensin II inhibits C184S in a 
competitive manner with respect to peptide substrate, 
containing residues 9-18 of phosphorylase b. In the presence 
of Mg2+, however, angiotensin II inhibits both wild type and 
C184S truncated y as a non-competitive inhibitor. These 
studies showed that angiotensin II bound differently to the 
truncated y subunit. Further studies suggest that C184S has a 
different preference for peptide substrates for tyrosine 
kinase activity, i.e., CDC2 peptide, RR-Src peptide, and Y-
peptide, from that of wild type truncated y. These results 
suggest that Cys-184 may play roles in the determination of 
substrate specificity of tyrosine kinase activity. 
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INTRODUCTION 
Phosphorylase kinase is a complex enzyme composed of four 
subunits, a, P,y, and 6, with a stoichiometry of («PyS) 4 (I-3) . 
It has been demonstrated that the y subunit contains the 
active site and catalyzes the transfer of the y-phosphoryl 
group from ATP to its acceptor, Ser-14 of phosphorylase 
The N-terminal region is partly homologous with the catalytic 
domain of cAMP-dependent protein kinase (cAPK) and other 
kinases (4). The C-terminal region, on the other hand, is 
thought to contain the calmodulin binding domain (5,6). 
There are seven cysteine residues in the y subunit (7) with 
six out of the seven free thiols in the catalytic domain 
(Figure 1). Four of them (Cys-36,-172,-184, and -197) are 
located in or near the active site region, predicted from the 
sequence alignment (4) and the crystal structure of cAMP-
dependent protein kinase (cAPK)(8-10). This is presumed to 
be the case if the structure of truncated y is closely related 
to cAPK. 
Previous studies (11) showed that the oxidation of the 
free sulfhydryl groups resulted in the formation of two 
intramolecular disulfide bonds. One of these disulfide 
bridges seems close to the nucleotide binding site and could 
insert a hindrance to the nucleotide binding. However, 
whether one or both cysteine residues are involved in the 
Calmodulin Binding 
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Figure 1. Location of Cys residues in the y subunit of phosphorylase kinase 
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nucleotide binding and/or recognition is not clear. In CaM-
dependent protein kinase II, Cys-30, which corresponds to 
Cys-3 6 of y, is suggested to be involved in the binding of ATP 
(12). This speculation was based on the observation that 
MgADP could protect CaM-protein kinase II from inactivation 
by DTNB and N-ethylmaleimide. 
The truncated form of 7 subunit (1-300), denoted as TR-y, 
was constructed and expressed in our laboratory (13). 
Previous studies suggest that TR-y has properties, such as 
metal ion response, pH-dependency, and Km values with respect 
to both substrates, similar to those of full length y but with 
a higher turnover rate (13). Most importantly, TR-y allows us 
to characterize the catalytic properties without the 
influence of the C-terminal calmodulin binding domain. 
Therefore, all of Cys-mutants were made in truncated y (1-300) 
form. Recently, phosphorylase kinase was found to contain 
tyrosine kinase activity and phosphorylate angiotensin II 
(14). The tyrosine kinase activity of Cys-mutants was also 
tested to learn whether substitution influences this newly 
identified activity of phosphorylase kinase. The first 
intra-molecular disulfide bond formed by oxidization has been 
localized by peptide mapping and sequencing (11). The 
location of the second dithiol bridge can help us to learn 
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more about the structure of y. To identify the second 
disulfide bond, Cys-mutants were oxidized with Cu2+ and the 
number of remaining free sulfhydryl groups were determined by 
DTNB titration. 
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EXPERIMENTAL PROCEDURES 
Materials 
Restriction enzymes were products of New England Biolabs 
or Promega. Angiotensin II, [Sar^,Ala^]-angiotensin II, and 
[Asnl,Val5]-angiotensin II were purchased from Sigma. CDC2 
and RR-Src peptides were kind gifts of Dr. Lee Graves. A 
peptide of residues 9-18 of phosphorylase b, phos 9-18 
peptide, and its tyrosine analog, Y-peptide, were synthesized 
by the Protein Facility at Iowa State University. 
Phosphorylase h was prepared as described (15). [y-^SpjATP 
was obtained from ICN. Econo Pac-IODG gel filtration column 
was from Bio Rad. Phosphocellulose and ET-31 papers were 
from Whatman. DTNB was purchased from Pierce. All other 
reagents were reagent grade. 
Oliaonucleotide-directed site-specific mutagenesis 
Olignucleotides used in site-directed mutagenesis were 
synthesized in the Nucleic Acid Facility at Iowa State 
University. Mutagenesis was performed using an Amersham 
commercial kit as described previously (13). Mutations were 
identified by restriction enzyme analysis and verified by 
sequencing. The Cys-mutants prepared in this study are C36S, 
C36A, C42S, C138S, C172S, C184S, and C197S. 
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Expression and Purification of Cvs-mutants 
Expression of wild type and Cys-mutants of TR-y was 
carried out by using a T7 RNA polymerase-based expression 
system (16) . All forms of TR-y were expressed as inclusion 
bodies. The inclusion bodies of recombinant proteins were 
solubilized, renatured, and purified as described previously 
(13) . 
Oxidation of Cvs-mutants bv copper ion 
The oxidation of Cys-mutants is essentially as described 
by Yuan and Graves (11) with some modification. The Cys-
mutants, after removing DTT, (0.2 mg/ml) were oxidized at pH 
7.8 by incubating with 16 |iM CuCl2 at room temperature for 
approximately 20 min. After incubation the oxidized proteins 
were mixed with 1 mM EDTA to stop the reaction before 
subjecting them to titration with DTNB. 
Determination of free sulfhvdrvl group 
The number of titratable sulfhydryl groups of the Cys-
mutants was determined by DTNB titration as described 
previously (11). Approximately 190 |ll protein (0.2 mg/ml) 
with or without Cu2+ treatment were mixed with solid urea. 
An appropriate amount of 0.4 M Na2HP04, pH 8.0 was added to 
give a total volume of 400 |ll. The final concentration of 
urea and phosphate is 6 M and 0.1 M, respectively. The 
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reaction was initiated by the addition of DTNB to 1 IDM. The 
mixture was incubated at room temperature for 15 min before 
measurement of absorbance at 414 nm. The concentration of 
sulfhydryl groups was calculated by using 6^24 = 13,600 M'^cm"! 
(17) . 
Activity assay 
The serine kinase activity of wild type TR-y and Cys-
mutants is determined by the incorporation of 32p into 
phosphorylase b- The assay is performed at pH 8.2 in the 
presence of 60 mM Tris-HCl, 60 mM HEPES, 10 mM MgCl2, 1 mM [y-
32p]ATP, and 100 JIM phosphorylase The final concentrations 
of TR-y and mutants are adjusted to around 0.6 nM. After 
incubating at 30 °C for 3 min a portion of aliquot is spotted 
on a square ET-31 paper (Whatman), washed with 
trichloroacetic acid, and analyzed by liquid scintillation 
counting (18). The tyrosine kinase activity is assayed as 
described previously (14). The reaction is performed in an 
assay mixture containing 10% glycerol, 50 mM Tris, 50 mM 
PIPES, pH 7.9, 3 mM MnCl2, 4 mM angiotensin II, and 1 mM [y-
32p]-ATP. The final concentrations of the truncated y subunit 
and mutants were 20 |lg/ml. The tyrosine kinase assay is 
allowed to proceed at 30°C for 15 min. After incubation, a 
portion of the reaction mixture is spotted on the phospho-
cellulose paper and washed with cold 0.5% phosphoric acid. 
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Miscellaneous methods 
The concentration of phosphorylase is determined 
spectrophotometrically (19). The concentrations of TR-y and 
its mutants are determined by the Bradford assay with 
commercially prepared reagent from Bio-Rad (20) . Peptide 
solutions are prepared based on their dry weight. SDS-
polyacrylamide gel electrophoresis is carried out with 
Laemmli's single buffer system (21) 
Kinetic data analysis - The kinetic data are analyzed 
with computer software Enzfitter (Elsevier Science 
Publishers). The initial velocity data are fitted to the 
equation for a two substrate random Bi Bi mechanism (eq 1) 
1/v = 1/V (1 + Kg/A + Kb/B + KiaKb/AB) (eq 1) 
The inhibition data are fitted into the equations for 
competitive (eq 2) or non-competitive inhibition (eq 3). 
1/v = 1/V [1 + Ka/A (1 + I/Kis)] (eq 2) 
1/y = 1/V [(1 + I/Kii) + Ka/A (1 + I/Kis)] (eq 3) 
Ka and Kb are the Michaelis constants for substrates A 
(phosphorylase) and B (ATP), respectively. Kia and Kib are 
defined as the dissociation constants for A and B from their 
respective binary complexes with the kinase. Kis and Kii are 
defined as: Kis = (I) (E • ATP) / (E • ATP • I) , and 
Kii = (I) (E • ATP • Phos) / (E • ATP • phos • I), respectively. 
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RESULTS 
Primary characterization of Cvs-mutants 
To determine the function of each free sulfhydryl group, 
especially those in the active site region, Cys residues were 
replaced with serine by site-directed mutagenesis. All Cys-
mutants can be renatured and purified to homogeneity as 
judged by SDS-polyacrylamide gel electrophoresis (Figure 2). 
The serine and tyrosine kinase activities of wild type and 
Cys-mutants are also compared (Figure 3). All Cys-mutants 
except C36S and C184S show similar kinase activities to those 
of wild type TR-y(data for C36A not shown). Both serine and 
tyrosine kinase activities are low in C36S (2-3%) . 
Interestingly, C184S has near normal serine kinase activity 
but shows only about 4-5% tyrosine kinase activity compared 
with that of wild type TR-y. 
Like wild type TR-y, all mutants can be partly inactivated 
by the oxidation of Cu2+ (data not shown). The number of 
free sulfhydryl groups of each Cys-mutant after oxidization 
is also determined by DTNB titration (Table I). All but two 
Cys-mutants, C42S and C138S, show the number of titratable 
sulfhydryl groups decreasing by two (or one disulfide bond 
formed) after treating with 16 |iM Cu2+. This result suggests 
that the four free thiols, Cys-36, -172, -184, and -197, are 
Figure 2. SDS-polyacrylamide gel electrophoresis of wild type truncated y and 
Cys-mutants. Around 10 |i.g protein was used per lane. Samples were 
electrophorsed with 12.5% polyacrylamide gel. 
WT 
C36S 
C42S 
C138S 
C172S 
C184S 
C197S 
SOI 
Figure 3. Serine and tyrosine kinases activity assay of 
wild type truncated y and Cys-mutants. Serine 
(open bar) and tyrosine kinases (close bar) 
activity assays were carried out as described 
under Experimental Procedures. 
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Table I 
Suimnary of DTNB-titratable Sulfhydryl Groups in 
Cys-Mutants after treating with 16 mM Cu2+ 
# of 
Mutants [SH]/molecule* Disulfide 
bond 
C36A® 3.1 ± 0.1 1 
C42S 1.3 ± 0.2 2 
C138S 1.6 ± 0.2 2 
C172S 3.1 ± 0.1 1 
C184S 2.6 ± 0.4 1 
C197S 2.8 ± 0.3 1 
* The oxidation and DTNB titration of Cys-
mutants were done as described under 
Experimental Procedures. 
® C3 6A instead of C36S was used in this 
experiment because the yield of C36S after 
purification is low. 
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involved in disulfide bonds formation after oxidation with 
Cu2+. 
Kinetic study of Cvs-36 mutants 
The C36S mutant has been found to have about 2-3 % of 
both serine and tyrosine kinase activities of the wild type 
enzyme. The C36A mutant, however, was made and exhibited 
similar kinase activities compared to wild type TR-y. Kinetic 
studies of both Cys-36 mutants, C36S and C3 6A, show similar 
Ka (20 ± 1 and 30.3 ± 0.8 |IM, respectively) and Kia (11 ± 2 
and 32 + 1 |iM, respectively) (Table II). The Kb (ATP) , 
however, are about 2-fold (133 ± 10 and 146 ± 5 HM, 
respectively) higher than that of the wild type kinase (79 ± 
10 |iM) . The Vm of C36A (4.8 ± 0.1 |i.mol/min/nmol) is similar 
to that of Wild type TR-y (4.10 ± 0.03 |J.mol/min/nmol) , while 
that of C36S (0.50 ± 0.01 |imol/min/nmol) is about 8-fold 
lower (Table II). These results suggest that Cys-36 may not 
be directly involved in the binding of the ATP because the 
replacement of Cys with Ala, containing a smaller hydrophobic 
side chain, does not change much the affinity of the protein 
for ATP. The replacement of Cys-36 with a serine may twist 
the nucleotide binding site and change either the distance 
between the y-phosphate and alcoholic group of Ser or the 
orientation of the y-phosphate with respect to the 
phosphorylatable OH group. 
Table II 
Comparison of Kinetic Parameters of Wild Type TR-y 
and Cys-36 Mutants of Phosphorylase Kinase® 
Phos B (MM) ATP (PM) 
TR-Y Ka Kia Kb Kib 
Vm 
(Hmol/min/ 
nmol) 
Wild Type 18 ± 1 24 ± 3 79 ± 10 105 ± 21 4.10 ± 0.03 
C36S 20 ± 1 11 ± 2 133 ± 10 73 ± 15 0.50 ± 0.01 
C36A 30.3 ± 0.8 32 ± 1 146 ± 5 152 ±5 4.8 ± 0.1 
^Kinetic studies were done at pH 8.2 in the presence of 10 mM 
Mg2+ as described under Experimental Procedures. The reaction 
was carried out by using phosphorylase b as the variable 
substrate(10-80 pM) and ATP as the fixed variable substrate 
(50-400 pM) . 
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Further characterization and kinetic studies of C184S 
Initial study shows that C184S has near normal serine 
kinase activity but has only 4-5% tyrosine kinase activity of 
that of wild type TR-y (Figure 3). The metal ion response of 
serine kinase activity of C184S (Figure 4A) is the same as 
that of wild type TR-y (13), while that of tyrosine kinase 
activity is different (Figure 4B). To learn more about the 
function of Cys-184, kinetic studies of serine kinase 
activity are performed by using phosphorylase b as substrate. 
The results of kinetic studies of the serine kinase activity 
in the presence of Mg2+ (Table III) show that C184S has 
similar Kb (53 ± 1 |m) , Kib (51.6 ± 0.5 |iM) , and Vm (3.20 ± 
0.05 jlmol/min/nmol) to those of wild type TR-y; however, Kia 
(55.9 ± 0.2 |iM) and Ka (58 ± 1 |1M) are about 2-3 fold higher. 
This observation suggests that Cys-184 may be involved in the 
binding of the protein or peptide substrate for the serine 
kinase activity of TR-y. Because the tyrosine kinase activity 
of C184S was very low using angiotensin II, it was not 
feasible to study its kinetics with this substrate. An 
alternate way to evaluate the binding characteristics of the 
mutant is to use angiotensin II as an inhibitor and study its 
effect on serine kinase activity. Angiotensin II inhibited 
the serine kinase activity of C184S in the presence of Mg2+ 
or Mn2+ (Figure 5) with the IC50 of around 6 and 4 mM, 
respectively. This is approximately the value of the Km for 
Figure 4. Metal ion responses of serine and tyrosine 
kinases of C184S. The serine (panel A) and 
tyrosine kinase (panel B) activity was 
assayed as described in Experimental 
Procedures except 0.2 mM ATP was used. 
Various amount (0 to 15 mM) of Mg2+ (-A-) and 
Mn2+ (-A-) were used in the activity assay. 
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Table III 
Comparison of Kinetic Parameters of Serine Kinase Activity of 
Wild Type TR-y and C184S Mutant# 
Phos b (MM) ATP (mm) 
TR-Y Ka Kia Kb Kib (Hmol/min/ 
nmol) 
Mg2+ ©vjT 18 ± 1 24 ± 3 79 ± 10 105 ± 21 4.10 ± 0.03 
C184S 58 ± 1 55.9 ± 0.2 53 ± 1 51.6 ± 0.5 3.20 ± 0.05 
# Kinetic studies were done as described in Experimental procedures. 
The initial rates were determined by using phosphorylase h as the 
variable substrate (20-120 |JM) and ATP as the fixed variable substrate 
(25-250 lOM) . 
©Huang, C.-Y. F. et al. (1993) Mol. Cell. Biochem. (in press). 
Figure 5. Inhibition of serine kinase activity of C184S 
mutant by angiotensin II in the presence of 
Mg2+ or Mn2+. Serine kinase activity assay 
was performed as described under Experimental 
Procedures except phos 9-18 peptide (50 |XM) 
was used as substrate. Inhibitory effect of 
angiotensin II (0.5 to 6 mM) was tested at pH 
7.9 in the presence of 10 mM Mg2+ (-0-) or 3 
mM Mn2+ (-•-) and 1 mM ATP. 
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angiotensin II of wild type truncated Y suggesting that the 
binding strength for a tyrosyl substrate is not changed much 
in the mutant. 
Further studies show that angiotensin II is a non­
competitive inhibitor (Figure 6A) for 9-18 peptide of 
phosphorylase b in the presence of Mg2+ with Kis and Kii of 
3.9 ± 0.4 and 4.2 ± 0.6 mM, respectively (Table IV). In the 
presence of Mn2+, however, it is a competitive inhibitor 
(Figure 6B) with a Kis of 3.3 ± 0.1 mM. A similar non­
competitive inhibition pattern is also obtained with wild 
type TR-y in the presence of Mg2+ (Table IV) but with about 
10-fold higher Kjs (37 ± 2 mM) for angiotensin II. These 
results further suggest that the low tyrosine kinase activity 
of C184S is not due to a lack of binding of the substrate. A 
difference between two recombinant proteins in binding 
between angiotensin II, a tyrosyl substrate, and 9-18 
peptide, a seryl substrate, is postulated according to the 
change in inhibition pattern with the binding of Mg2+ or Mn2+ 
(Table IV). 
An active site containing two conformations in TR-y with 
the binding of different metal ions, e.g., Mg2+ or Mn2+, has 
been proposed by Yuan et al. (14) to explain the metal-ion 
dependent dual specificity of phosphorylase kinase. One 
active site conformation favors the seryl phosphorylation and 
the other tyrosyl phosphorylation. This conformational 
Figure 6. Inhibition pattern of C184S by angiotensin II 
in the presence of Mg2+ or Mn2+. Serine 
kinase activity was assayed as described in 
Experiment Procedures. A) inhibition of C184S 
by angiotensin II in the presence of Mg2+ with 
phos 9-18 peptide as the variable substrate 
(0.5-4 mM) . The final concentrations of 
angiotensin II in the assay were from 0 to 2 
mM as indicated. B) Inhibition of C184S by 
angiotensin II in the presence of Mn2+ with 
phos 9-18 peptide as variable substrate (0.6-6 
mM) . The final concentrations of angiotensin 
II were from 0 to 3 mM as indicated. The 
concentration of [y-^^p] was 1 mM in both 
assays. 
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Table IV 
Summary of the kinetic studies of wild type truncated y and 
C184S mutant using angiotensin II as substrate or inhibitor 
, Inhibition 
TR-y ion Kii Km Pattern 
(MM) (jiM) (MM) 
WT Mg 37 ± 2 8 ± 2 _ N C 
@Mn 3.4 ± 0.3 _ 4.4 ± 0.2 
C184S Mg 3.9 ± 0.4 4.2 ± 0.6 _ NC 
Mn 3.3 ± 0.1 _ C 
® This is the Kia and Ka values of wild type truncated y 
for angiotensin II. 
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change caused by the binding of metal ions in the second 
metal ion binding site is further demonstrated by the 
observation that the sedimentation velocity of TR-y with Mg2+ 
or Mn2+ was different in the XLA Beckman analytical 
centrifuge. The TR-y subunit in the presence of Mn^+ exhibits 
a higher sedimentation velocity in ultracentrifuge than that 
in the presence of Mg2+ (Luo and Yuan unpublished data). 
This result suggests that TR-y may have a more compact 
structure in the presence of Mn2+ than in the presence of 
Mg2+ because sedimentation velocity is inversely proportional 
to the size and the shape of the molecules with the same 
molecular mass. 
Substrate specificity of C184S 
Several common tyrosine kinase substrates, angiotensin 
II and derivatives, CDC2 peptide, and RR-Src peptide, and 
other tyrosine bearing peptides were used (Table V) to study 
the specificity of tyrosine phosphorylation with the wild 
type and C184S mutant TR-y. As shown in the top panel of 
Figure 7 wild type TR-y strongly prefers angiotensin II and 
its derivatives, Sar^-,Ala^- and Asn^,Val^-angiotensin II, as 
tyrosine kinase substrates. Mn2+ is required for these 
reactions. In contrast, the Cys-184 mutant shows a different 
substrate specificity and a metal ion requirement (bottom 
panel of Figure 7). C184S prefers CDC2 peptide, RR-Src 
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Table V 
Peptide Substrates for the Tyrosine Kinase Activity of 
truncated y of phosphorylase Kinase 
Peptides Sequences 
Phos 9-18 KRKQISVRGL 
Ang II DRVYIHPF 
SA-Ang II SRVYIHPA 
NV-Ang II NRVYVHPF 
Y-Peptide KRKQIYVRGL 
C D C 2  R R K I E K I G E G A Y G V V F K  
RR-Src RRLIEDAEYAARG 
I 
Figure 7. Substrate specificity of the tyrosine kinase 
activity of wild type truncated y and C184S 
mutant. Tyrosine kinase activity of wild type 
truncated y (top penal) and C184S mutant 
(bottom penal) was assayed as described in 
Experimental Procedures in the presence of 
1 mM [y-32p]-ATP and 10 mM Mg2+ (open bar) or 
3 mM Mn2+ (close bar). The final 
concentrations of peptide substrates were 1 
mM. 
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peptide, and Y-peptide as substrates in comparison to 
angiotensin II. In addition, Mg2+ is more effective than 
Mn2+ for the tyrosine kinase activity of C184S. This result 
suggests that Cys-184 is important for the determination of 
tyrosine kinase substrate specificity. 
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DISCUSSION 
Four out of seven free sulfhydryl groups, C36S, C172, 
C184S, and C197S, have been predicted to be located in or 
near the active site region of the catalytic subunit of 
phosphorylase kinase based upon the crystal structure of 
cAMP-dependent protein kinase (8-10) and primary sequence 
alignment of the kinases (4). Previous studies (11) suggest 
that two intramolecular disulfide bridges can be formed by 
the oxidation caused by Cu2+. One of these two disulfide 
bonds has been located between Cys-3 6 and Cys-172 by peptide 
mapping and sequencing (11). As shown in Table I, only C42S 
and C138S can form two disulfide bond (around four free 
sulfhydryl groups/molecule disappear) after treating with 16 
liM Cu2+. With this concentration of Cu^"*", two disulfide 
bonds could be formed in wild type TR-y. if a certain 
cysteine in the wild type kinase is involved in the formation 
of the disulfide bond, two disulfide bonds should not be 
expected to be found in the mutant which replaced that Cys 
with Ser or Ala. Hence, we conclude that Cys-3 6, -172, -184, 
and -197, are involved in the formation of disulfide bonds. 
Accordingly, the second disulfide bridge should be located 
between Cys-184 and Cys-197. 
All seven Cys-mutants, C36A, C36S, C42S, C138S, C172S, 
C184S, and C197S, were tested for their serine and tyrosine 
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kinase activities. Among the seven mutants only C3 6S and 
C184S show interesting results. Cys-36 is interesting 
because it is on P-sheet 2 of the small lobe, which is close 
to the nucleotide binding site of y, according to the crystal 
structure of cAPK (4,8). This observation suggests that the 
side chain of Cys-36 may be in the region of the ATP binding 
domain and play a role in nucleotide binding and/or 
recognition. In the case of CaM-dependent protein kinase II, 
Cys-30, corresponding to Cys-36 of y, was also suggested to be 
involved in nucleotide binding (12). However, kinetic 
studies of C36S and C3 6A (Table II) reveal that Cys-3 6 may 
not be directly involved in nucleotide binding and/or 
recognition in the y subunit. This is because the replacement 
of Cys by a smaller hydrophobic residue, Ala, did not change 
much the affinity of Cys-mutant for ATP. An alteration in 
the structure of P-sheet 2 by the replacement of Cys with Ser 
could occur. This structure alteration may change either the 
orientation of the y-phosphate of ATP or the distance between 
y-phosphate and the acceptor hydroxy1 group and affect the 
phosphotransferase activity. 
Although the catalytic domain among kinases is highly 
conserved according to primary sequence alignment (11), 
several variable sites are proposed to play a role in 
determining the substrate specificity in the kinase family 
(9). Among these variable sites the protein substrate 
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binding loop (PSB loop), between P-sheet 9 and F-helix, is 
important (8,9). For example, it has an important role in 
anchoring inhibitory peptide, PKI(5-24), in cAPK (9). The 
modification of Cys-199 in the PSB loop by a thiol specific 
reagent or a peptide analog specific for thiol group could 
totally block the enzyme activity (23,24). The crystal 
structure of cAPK suggests that the sulfhydryl group of Cys-
199 is in close proximity with the P+1 site of PKI peptide 
(9) and contributes to the general hydrophobic environment 
around the P+1 site. In addition, the mutagenesis of Cys-199 
to Val increases the Km for peptide substrate without 
changing kinase activity (25). In case of CDK2, the T loop, 
which corresponds to the PSB loop of cAPK, was suggested to 
be highly dynamic and flexible and act as an auto-inhibitor 
to block the entrance of the active site cleft before 
autophosphorylation and cyclin binding (22). In the y subunit 
of phosphorylase kinase this region is even more important 
because it is involved not only in the binding of serine 
kinase substrate but also in the determination of substrate 
specificity of tyrosine kinase activity. When Cys-184 of TR-
y, corresponding to Cys-199 of cAPK, is replaced with serine, 
the Km of C184S mutant for phosphorylase b increases about 3-
fold (Table III). This result suggests that Cys-184 may not 
be crucial in the interaction of serine kinase substrate. 
More dramatic results were obtained from the effect of 
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mutagenesis of Cys-184 on the tyrosine kinase activity. The 
primary characterization shows that C184S contains only 4-5% 
tyrosine kinase activity with angiotensin II as substrate. 
Further characterizations of C184S show that mutagenesis does 
not abolish the binding of angiotensin II (Table IV) but 
switches the substrate preference from angiotensin II to CDC2 
peptide, RR-Src peptide, and Y-peptide (Figure 7). 
An active site model is proposed (Figure 8) to explain 
the metal ion-dependent dual specificity of phosphorylase 
kinase. In the presence of Mg2+ the active site region may 
be shallower than in the presence of Mn2+ and just fit the 
alcoholic group of serine kinase substrate. With this 
conformation the binding of tyrosine kinase substrate will be 
restricted and make phenolic group of tyrosyl residue out of 
the active site region. With Mn2+ at the second metal ion 
binding site, however, the active site region of y becomes 
deeper and can accommodate the bulky phenolic group of 
tyrosyl residue. A conformational change may also occur in 
the flexible PSB loop in the presence of Mn2+ and help to 
anchor the tyrosine kinase substrate, angiotensin II, in the 
active site region. The conformational change resulting from 
the binding of Mn2+ could also affect the catalytic base of 
the kinase by twisting it away from the phosphorylation site. 
This may partly explain the inhibitory effect of Mn2+ to 
serine kinase activity. The replacement of Cys-184 to Ser 
Figure 8. Active site model of the y subunit of 
phosphorylase kinase for substrates of serine 
and tyrosine kinases in the presence of Mg2+ 
or Mn2+. The catalytic base is shown as 
-B: . 
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may either change the local conformation or flexibility of 
PSB loop and make it unable to bring a tyrosyl residue of 
angiotensin II to an optimal position in the active site. 
Instead other tyrosyl residue bearing peptides, CDC2 peptide, 
RR-Src-peptide, and Y-peptide, might reach the y-phosphoryl 
group of ATP in the active site region with this 
conformational change. 
Angiotensin II was reported by Garcia et al. (26) that it 
could form two tight turns when bound to its receptor. The 
possibility that protein tyrosine kinases recognize tyrosyl 
residue in a P-turn was also proposed by Tinker et al. (27). 
Phosphorylase kinase recognizes its tyrosine kinase substrate 
by a certain secondary structure in the phosphorylation site 
region is also speculated. Although the secondary structure 
of CDC2, RR-Src peptide, and Y-peptide are unknown so far, we 
believe they will be proved to be distinct from that of 
angiotensin II. 
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GENERAL SUMMARY AND DISCUSSION 
Phosphorylase kinase is a complicated enzyme not only 
because of its subunit composition but also because of its 
regulation and substrate specificity. Evidence from our lab 
and others suggest that it can phosphorylate not only 
serine/threonine (67-70,73) but also on tyrosine residues 
(83). This unique property makes phosphorylase kinase a 
different class of protein kinase, termed dual-specificity 
protein kinase (84). Different from other dual-specificity 
kinases, e.g., MAP kinase kinase (85-87), phosphorylase 
kinase requires metal ions, i.e., Mg2+ and Mn2+, as a switch 
for different kinase activities (83). One metal ion 
activates one kinase activity and inhibits the activity of 
another and vice versa. One active site containing two 
different kinase activities of phosphorylase kinase was 
proposed (83) according to the observation that both serine 
and tyrosine kinase activities are inactivated by the 
oxidation by Cu2+. A conformational change in the active 
site region upon the binding of metal ion, i.e., Mn^+, is 
proposed. This speculation is supported by the observation 
that TR-y exhibits different sedimentation velocities in the 
presence of Mg2+ or Mn^+. In the presence of Mn2+, TR-y was 
found to move faster than in the presence of Mg2+ in the 
ultracentrifuge. Because sedimentation velocity is inversely 
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proportional to the size of the molecules with the same 
molecular mass, a more compact structure of the TR-y subunit 
caused by the binding of Mn2+ was speculated. The results 
from Yuan and Graves (39) and Bollen et al. (82) further 
support the idea of one active site containing two 
conformations in y. The Dansyl-calmodulin • Ca2+ complex was 
found to bind differently with the HPLC-purified renatured y 
subunit in the presence of Mg2+ or Mn^+. A conformational 
change in y by the binding of different metal ions was 
suggested to make Dansyl-calmodulin bind differently (39). 
Phosphorylase kinase was also found to recognize two 
different peptide substrates, syntide 2 and syntide 3, in the 
presence of Ca2+ or heparin (82). One active site containing 
two different conformations caused by the binding of 
different ligands was also proposed. 
The y subunit of phosphorylase kinase may share some 
structural features with those of cAMP-dependent protein 
kinase (cAPK) (88-91) based on the primary sequence alignment 
among kinases (26). However, some unique structural features 
in y are also expected based on its metal ion response, 
substrate specificity, and regulation. By using the 3D 
structure of cAPK as a model, we compared the structure of y 
and cAPK based on the studies of the function of free 
sulfhydryl groups by biochemical and molecular biological 
approaches and the tyrosine kinase activity of y. We conclude 
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that first, like cAPK, y of phosphorylase kinase also has a 
flexible catalytic domain. It has been found that cAPK 
contains the open and closed structures upon the binding of 
substrate (92,93). The small lobe of cAPK can move 15-39° 
related to large lobe. However, the movement between small 
and large lobes in y may be larger. This is suggested by the 
location of first disulfide linkage between Cys-3 6 and Cys-
172. Since Cys-36 and Cys-172 could be readily oxidized by 
low concentration of Cu2+, the thiol groups from two Cys 
residues may be in close proximity. In the other words, the 
active site cleft between small and large lobes may be much 
narrower than it is in the crystal structure of cAPK (88-91). 
The binding of substrates may fix the active site at a 
certain conformation. This idea was supported by the 
observation that MgATP could protect truncated y from 
inactivation at low concentration of Cu2+. 
Second, E-helix and Cys-138 in y may play a role in the 
interaction with other subunits, a and/or (3, or its own C-
terminal calmodulin binding domain. The Glu-155 in E-helix 
of cAPK, corresponding to Cys-138 of y, was found to face the 
acyl-binding pocket and interact with a myristyl group. The 
binding of myristyl group stabilizes the structure of C 
subunit of cAPK (92,94). In TR-y the cross-linking of Cys-
peptide to Cys-138 results in slightly increasing Km values 
for phosphorylase b and ATP (about 2-fold) and decreasing Vm 
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(about 3-fold). A restriction in the conformational change 
could be provided by Cys-peptide. Meanwhile a different pH-
activity curve of Cys-peptide coupled TR-y was found from that 
of wild type kinase. A higher pKa value for the catalytic 
base in the Cys-peptide coupled TR-y subunit is suggested by 
this result. Accordingly, the environment of the catalytic 
base in Cys-peptide coupled TR-y becomes more hydrophobic 
because of the coupling of Cys-peptide. Without the 
restriction provided by the coupled Cys-peptide, TR-y may 
adjust its active site region more effectively to an optimal 
conformation. The conformational change in active site 
region of y results in the exposure of its catalytic base and 
accommodating the incoming substrates. A similar pH-activity 
curve as in Cys-peptide coupled TR-y was also seen in ayS 
complex and non-activated phosphorylase kinase holoenzyme 
(22). These results suggest that Cys-138 in y may have a 
interaction with either regulatory subunit, a or (3, or with 
its C-terminal calmodulin binding domain. The interaction of 
the regulatory subunits or C-terminal calmodulin binding 
domain to this region may regulate the phosphotransferase 
activity of the y subunit. This speculation is partly 
suggested by the results that TR-y has higher Vm and lower Km 
values for both substrates (34) than those of various forms 
of phosphorylase kinase (1,22,25,61). 
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Third, Cys-184 may have a role in determining the 
substrate specificity of tyrosine kinase activity of 
phosphorylase kinase. The Cys-199 of cAPK, which corresponds 
to Cys-184 of 7, was found to be in close proximity with the 
P+1 site of PKI peptide (90) and contribute to the general 
hydrophobic environment around the P+1 site. The replacement 
of Cys-199 to Val change the Km for peptide substrate but not 
the Vm of cAPK (95). A steric hindrance provided by Val side 
chain was suggested. In TR-y, when replacing Cys-184 with 
Ser, the tyrosine kinase activity of TR-y was reduced by 
approximately 20-fold by using angiotensin II as substrate. 
Meanwhile the serine kinase activity of TR-y is roughly the 
same. Kinetic studies show that the mutation changed the Km 
for phosphorylase b by 3-fold but the binding strength of 
mutant for angiotensin II is about the same. Further study 
suggests that C184S has a different preference for 
substrates, i.e., CDC2 peptide, RR-Src peptide, and Y-
peptide, from that of wild type truncated y. This result 
along with others suggests that Cys-184 may play a role in 
the binding of serine kinase substrate and most importantly 
in the determining the substrate specificity of tyrosine 
kinase activity. 
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